• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Election 2025
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Election 2025
  • Government Shutdown
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Alzheimer's

    Tag: Alzheimer's

    Anticipation and skepticism surround Alzheimer’s drug on fast track for approval
    Healthcare

    Anticipation and skepticism surround Alzheimer’s drug on fast track for approval

    Abigail Adcox -
    November 28, 2022 9:00 pm
    0
    Experimental Alzheimer’s drug fails to slow cognitive decline in clinical trials
    News

    Experimental Alzheimer’s drug fails to slow cognitive decline in clinical trials

    Abigail Adcox -
    November 14, 2022 4:36 pm
    0
    The Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass.  Shares of Biogen and other drugmakers researching Alzheimer’s disease soared early Wednesday, Sept. 28, 2022, after Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease’s progress in a late-stage study. Eisai announced results late Tuesday from a global study of nearly 1,800 people with early-stage Alzheimer’s.
    Healthcare

    Experimental Alzheimer’s drug slows cognitive decline in late-stage study

    Abigail Adcox -
    September 28, 2022 3:59 pm
    0
    SEE IT: 90210 cast pays tribute to late Joe E. Tata
    News

    SEE IT: 90210 cast pays tribute to late Joe E. Tata

    Maria Leaf -
    August 26, 2022 1:22 am
    0
    Memory, Liam Neeson’s latest, is forgettable
    Crime

    Memory, Liam Neeson’s latest, is forgettable

    Daniel Ross Goodman -
    May 6, 2022 3:00 am
    0
    Medicare proposes limited coverage for controversial Alzheimer’s treatment
    Healthcare

    Medicare proposes limited coverage for controversial Alzheimer’s treatment

    Cassidy Morrison -
    January 11, 2022 11:43 pm
    0
    WATCH: Maine State trooper rescues elderly man with Alzheimer’s
    News

    WATCH: Maine State trooper rescues elderly man with Alzheimer’s

    Heather Hamilton -
    December 23, 2021 5:33 pm
    0
    Police allege woman told husband he had Alzheimer’s to steal $600,000 over 20 years
    News

    Police allege woman told husband he had Alzheimer’s to steal $600,000 over 20 years

    Elizabeth Faddis -
    November 2, 2021 4:14 pm
    0
    London cab drivers’ brains to be studied for Alzheimer’s research
    News

    London cab drivers’ brains to be studied for Alzheimer’s research

    Asher Notheis -
    November 1, 2021 3:56 pm
    0
    FDA panel criticizes agency approval of controversial $56,000 Alzheimer’s drug
    Healthcare

    FDA panel criticizes agency approval of controversial $56,000 Alzheimer’s drug

    David Hogberg -
    July 28, 2021 9:33 pm
    0
    1234...6Page 3 of 6
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter